[ Price : $8.95]
Five consumer advocacy groups ask FDA for stronger labeling to describe adverse events associated with Pfizers Chantix.[ Price : $8.95]
FDA issues a complete response letter to Aeterna Zentaris citing reasons why its Macrilen cannot be approved as a means to evaluat...[ Price : $8.95]
FDA says it will use a new clinical trial protocol to speed development of Ebola drugs.[ Price : $8.95]
Former FDA liaison to the European Medicines Agency David Martin says it is important that the two regulatory bodies maintain a li...[ Price : $8.95]
The CDER Office of Prescription Drug Promotion cautions Sciecure Pharma about false and misleading presentations in a Doral sales ...[ Price : $8.95]
FDA collaborates with the Multiple Myeloma Research Foundation, the National Cancer Institute, and other groups to accelerate the ...[ Price : $8.95]
King and Spalding attorney Pamela Forrest says FDA modified a draft guidance on medical device enhancements and recalls to elimina...[ Price : $8.95]
CDER issues a MAPP on the Office of Translational Sciences management of the regulatory science and review enhancement program.